Home Molecular markers detecting circulating melanoma cells by reverse transcription polymerase chain reaction: methodological pitfalls and clinical relevance
Article
Licensed
Unlicensed Requires Authentication

Molecular markers detecting circulating melanoma cells by reverse transcription polymerase chain reaction: methodological pitfalls and clinical relevance

  • Adrianos Nezos , Peter Lembessis , Antigone Sourla , Nikolaos Pissimissis , Helen Gogas and Michael Koutsilieris
Published/Copyright: December 5, 2008

Abstract

Herein, we expound the theory of circulating melanoma cells (CMCs) and their detection with reverse transcription polymerase chain reaction as a molecular staging approach. We discuss the molecular markers that have been used for CMC detection focusing on the use of these markers for multiplex detection analysis. Finally, we comment on the contradictory data of CMC detection studies in the literature and we propose possible solutions which may contribute to the clinical significance of CMC detection in patient management.

Clin Chem Lab Med 2009;47:1–11.


Corresponding author: Michael Koutsilieris, MD, PhD, Professor and Head, Department of Experimental Physiology, Medical School, University of Athens, 75 Mikras Asias, Goudi 115 27, Athens, Greece Phone: +30-210-7462597, Fax: +30-210-7462571,

Received: 2008-5-27
Accepted: 2008-9-22
Published Online: 2008-12-05
Published Online: 2008-12-5
Published in Print: 2009-01-01

©2009 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Reviews
  2. Molecular markers detecting circulating melanoma cells by reverse transcription polymerase chain reaction: methodological pitfalls and clinical relevance
  3. HIV-GB virus C co-infection: an overview
  4. Genetics and Molecular Diagnostics
  5. Relationships between C-reactive protein concentration and genotype in healthy volunteers
  6. SYBR Green-based real-time PCR assay for detection of VKORC1 and CYP2C9 polymorphisms that modulate warfarin dose requirement
  7. Functional polymorphisms in ACE and CYP11B2 genes and atrial fibrillation in patients with hypertensive heart disease
  8. No effect of MDR1 C3435T polymorphism on oral pharmacokinetics of telmisartan in 19 healthy Chinese male subjects
  9. A novel large deletion and three polymorphisms in the FECH gene associated with erythropoietic protoporphyria
  10. Aging and endothelial progenitor cell telomere length in healthy men
  11. Gln222Arg (A2317G) polymorphism in the deoxyribonuclease I gene exhibits ethnic and functional differences
  12. Mutation screening of the medium-chain acyl-CoA dehydrogenase (MCAD) and the ornithine transcarbamylase (OTC) genes by multiplex PCR amplification and sequencing
  13. General Clinical Chemistry and Laboratory Medicine
  14. Nitrated apolipoprotein A-I, a potential new cardiovascular marker, is markedly increased in low high-density lipoprotein cholesterol subjects
  15. Relationships of serum haptoglobin concentration with HbA1c and glycated albumin concentrations in Japanese type 2 diabetic patients
  16. Multi-elements (aluminium, copper, magnesium, manganese, selenium and zinc) determination in serum by dynamic reaction cell-inductively coupled plasma-mass spectrometry
  17. Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients
  18. Validation and Outcome Studies
  19. Validation for quantification of immunoglobulins by Fourier transform infrared spectrometry
  20. Albumin-based or albumin-linked calibrators cause a positive bias in serum proteins assayed by the biuret method
  21. Current practices in antinuclear antibody testing: results from the Belgian External Quality Assessment Scheme
  22. Verification of the analytical range of a new reagent for full-range C-reactive protein determination
  23. Measurement uncertainty in manual differential leukocyte counting
  24. Letters to the Editor
  25. Falsely elevated carbohydrate antigen 19-9 level due to heterophilic antibody interference but not rheumatoid factor: a case report
  26. An unusual interference in parathormone assay caused by anti-goat IgG: a case report
Downloaded on 2.8.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.009/html
Scroll to top button